Nagami GT. Role of angiotensin II in the enhancement of ammonia production and secretion by the proximal tubule in metabolic acidosis. Am J Physiol Renal Physiol 294: F874-F880, 2008. First published February 20, 2008 doi:10.1152/ajprenal.00286.2007.-Acidosis and angiotensin II stimulate ammonia production and transport by the proximal tubule. We examined the modulatory effect of the type 1 angiotensin II receptor blocker losartan on the ability of metabolic acidosis to stimulate ammonia production and secretion by mouse S2 proximal tubule segments. Mice given NH 4Cl for 7 days developed metabolic acidosis (low serum bicarbonate concentration) and increased urinary excretion of ammonia. S2 tubule segments from acidotic mice displayed higher rates of ammonia production and secretion compared with those from control mice. However, when losartan was coadministered in vivo with NH 4Cl, both the acidosisinduced increase in urinary ammonia excretion and the adaptive increase in ammonia production and secretion of microperfused S2 segments were largely blocked. In renal cortical tissue, losartan blocked the acid-induced increase in brush-border membrane NHE3 expression but had no effect on the acid-induced upregulation of phosphate-dependent glutaminase or phosphoenolpyruvate carboxykinase 1 in cortical homogenates. Addition of angiotensin II to the microperfusion solution enhanced ammonia secretion and production rates in tubules from NH 4Cl-treated and control mice in a losartaninhibitable manner. These results demonstrate that a 7-day acid challenge induces an adaptive increase in ammonia production and secretion by the proximal tubule and suggest that during metabolic acidosis, angiotensin II signaling is necessary for adaptive enhancements of ammonia excretion by the kidney and ammonia production and secretion by S2 proximal tubule segments, as mediated, in part, by angiotensin receptor-dependent enhancement of NHE3 expression. ammonia transport; ammoniagenesis; acid-base physiology; losartan; sodium-hydrogen exchanger A MAJOR WAY that the kidneys defend the body against the introduction of excess acid is through the production and excretion of total ammonia (tNH 3 ϭ NH 3 ϩ NH 4 ϩ ) (15, 21, 29, 33, 36) . The proximal tubule is the major site of this response to acid challenges, increasing its rates of tNH 3 production and secretion and generating new bicarbonate formation (8, 26) . We previously demonstrated that chronic metabolic acidosis in vivo stimulates tNH 3 production and secretion by mouse S2 proximal tubule segments (24). The increased rates of ammoniagenesis persist even after the tubule is removed from the acidotic animal and assayed in vitro under normal pH conditions. Such adaptive changes result from the induction of key ammoniagenic enzymes (5, 37).
A MAJOR WAY that the kidneys defend the body against the introduction of excess acid is through the production and excretion of total ammonia (tNH 3 ϭ NH 3 ϩ NH 4 ϩ ) (15, 21, 29, 33, 36) . The proximal tubule is the major site of this response to acid challenges, increasing its rates of tNH 3 production and secretion and generating new bicarbonate formation (8, 26) . We previously demonstrated that chronic metabolic acidosis in vivo stimulates tNH 3 production and secretion by mouse S2 proximal tubule segments (24) . The increased rates of ammoniagenesis persist even after the tubule is removed from the acidotic animal and assayed in vitro under normal pH conditions. Such adaptive changes result from the induction of key ammoniagenic enzymes (5, 37) .
In our previous study, short-term (18-h) acid challenges induced an adaptive enhancement in the rate of tNH 3 secretion, but not production in an angiotensin II (ANG II)-dependent manner (22) . Giving the acid challenge concurrently with a type 1 ANG II (AT1) receptor blocker, losartan, blocked the acid-induced increase in tNH 3 secretion that was observed with the short-term acid challenge. It is well-known that during metabolic acidosis, the systemic renin-angiotensin system is stimulated (9, 28, 31) , but the role of this system in the renal response to chronic acid challenges is unknown. Studies by others also demonstrated that local concentrations of ANG II in the kidney are substantial (3, 25, 34) and may act in a paracrine fashion (30) . As ANG II directly stimulates tNH 3 production and secretion by the proximal tubule (4, 19, 20) , it may mediate a portion of the adaptive enhancement of tNH 3 production and secretion that is observed with metabolic acidosis.
The purposes of the present studies were to test whether AT1 receptor blockade alters the acidosis-induced adaptive increase in urinary tNH 3 excretion and S2 proximal tubule segment rates of tNH 3 production and secretion, to examine the effects of AT1 receptor blockade on the adaptive upregulation of key proteins involved in ammonia production and transport, and to determine the direct effects of ANG II in vitro on tNH 3 production and secretion by S2 segments from control and NH 4 Cl-treated mice. We found that NH 4 Cl-induced metabolic acidosis enhanced tNH 3 excretion by the kidney and tNH 3 production and secretion rates by mouse S2 proximal tubule segments in a losartan-inhibitable manner. In addition, metabolic acidosis enhanced the expression of renal cortical phosphate-dependent glutaminase (PDG) and phosphoenolpyruvate carboxykinase 1 (PCK1) and cortical brush-border membrane (BBM) NHE3 protein expression but only the enhancement of NHE3 expression was prevented by the provision of losartan with the acid load. The addition of ANG II in vitro to the lumen of microperfused S2 segments further stimulated rates of tNH 3 production and secretion in a losartan-inhibitable manner. measurement of serum total CO2 and potassium concentration. Urine was obtained from the bladder for determination of tNH3 and creatinine, and urine pH was immediately estimated using pH paper in conjunction with standard pH solutions.
Microperfusion of mouse proximal tubule segments. S2 segments of the mouse proximal tubule comprising the late convoluted and early straight portions (0.9 Ϯ 0.2 mm) were dissected from outer cortical nephrons under direct microscopic visualization. Each S2 segment was placed in a temperature-regulated chamber mounted over the objective of an inverted microscope and was microperfused using concentric pipettes so that the luminal aspect of the S2 segment was cannulated and perfused with Krebs-Ringer bicarbonate (KRB) buffer (16, 17) . The flow rates (20.1 Ϯ 0.3 nl/min) did not differ among the groups studied. The S2 segment was bathed in ϳ300 l KRB buffer containing 0.5 mM L-glutamine pregassed with 95% O 2-5% CO2, pH 7.4 at 37°C.
Measurement of tNH3 production rates. In studies measuring tNH3 production rates by isolated perfused S2 segments, the bath solution was covered with pregassed mineral oil and continuously bubbled with a gas jet of 95% O 2-5% CO2. The distal end of the perfused segment remained open to the bath medium so that tNH3 entered the bath solution via the fluid leaving the distal end of the perfused segment and via direct release into the bath medium through the basolateral aspect of the S2 segment. At the end of a 20-to 30-min incubation period, an aliquot of the bath solution was taken for analysis of tNH 3 using a microenzymatic method coupling the conversion of 2-oxoglutarate, NADH and tNH3 to NAD ϩ and glutamate (16) . The volume of the bath solution was determined from the degree of dilution of Trypan blue dye added in known amounts to the bath solution at the completion of the study.
Measurement of luminal tNH 3 secretion rates. In studies examining luminal tNH3 secretion rates, the fluid leaving the distal end of the perfused segment was collected with a pipette (16, 23) . Luminal tNH3 secretion rates equaled the rate at which tNH3 left the distal end of the perfused segment in timed luminal fluid collections. Under the in vitro microperfusion conditions employed, the tNH 3 production and secretion rates were stable for Ͼ45 min after onset of tubule incubation in vitro. All studies were completed within that time period.
Preparation of proteins from renal cortical tissue. Mice were given control diets with or without losartan or 7-day NH 4Cl loads as noted above. At the end of 7 days, mice were euthanized, kidneys were removed, and renal cortical tissue was dissected. Isolated tissue was placed in a mannitol buffer [150 mM mannitol, 80 mM HEPES, pH 7.5, 0.2 mM EDTA with antiprotease cocktail (Roche)], homogenized with a Polytron homogenizer, and the homogenate was centrifuged at 200 g for 10 min (4°C). An aliquot of the supernatant was taken for total protein determination in the crude homogenate, placed in lysis buffer [330 mM sucrose, 20 mM Tris, pH 7.5, 0.2 mM EDTA, 1% Triton X-100, 0.5% NP-40 and antiprotease cocktail (Roche)], and kept on ice for 20 min. The lysed homogenate was centrifuged at 14,000 g at 4°C for 20 min, the protein concentration of the supernatant was determined, and the samples were stored at Ϫ80°C for subsequent immunoblot analysis.
Preparation of BBM proteins. After the aliquot for total proteins was taken, the remainder of the supernatant of the crude homogenate was used to prepare BBMs, as described by Booth and Kenny (2) and modified by Karniski et al. (12, 13) . The supernatant of the homogenate was treated with magnesium sulfate to bring the final concentration of magnesium to 11 mM. The preparation was mixed at 4°C for 20 min and then processed through a series of low-speed centrifugations (2,300 g ϫ 8 min, 3,800 g ϫ 8 min, 4,400 g ϫ 8 min), each time saving the supernatant until a high-speed centrifugation step (14,000 g for 12 min) was performed to harvest the BBM vesicles. The pelleted vesicles were resuspended in lysis buffer and kept on ice with intermittent mixing for 20 min before protein assay and storage.
Immunoblotting of protein preparations. Sixty micrograms of isolated proteins from the homogenate or 100 g from the BBM prepration were denatured under reducing conditions and separated by SDS-PAGE on 4 -12% gradient gels (Invitrogen). The separated proteins were electroblotted (Owl semidry electroblotter) to nitrocellulose membranes for immune staining for glutaminase, PCK1, or NHE3 using an anti-glutaminase antibody (kind gift of Dr. N. Cuthoys), anti-PCK1 antibody (Cayman Chemical), or anti-NHE3 antibody (kind gift of Dr. O. Moe), respectively. Secondary antibody, chemiluminescent detection kit (Pierce), and scanning densitometry were used to determine relative expression after exposing the membranes to the primary antibodies. Immunblotting was performed on three sets of mice exposed to sucrose alone, sucrose ϩ losartan, sucrose ϩ NH 4Cl, and sucrose ϩ NH4Cl and losartan.
Measurements of total CO2 and potassium concentrations. Total CO2 (tCO2 ϭ HCO 3 Ϫ ϩ dissolved CO2) was determined on serum samples enzymatically using the phosphoenolpyruvate carboxykinase reaction (Sigma Chemical). The measurements were linear over the range of concentrations observed. Potassium measurements were made by ion-sensitive electrode (18) .
Solutions. KRB buffer solution contained the following electrolytes (in mM) 125 NaCl, 25 NaHCO 3, 5 KCl, 1 MgCl2, 1 NaH2PO3, and 1 CaCl2. ANG II and losartan (Merck) were used in the concentrations specified in the results. The low (25 mM) sodium perfusion solution substituted N-methylglucamine chloride for NaCl in the KRB buffer solution. All glutamine-containing solutions were freshly prepared using the purest form of L-glutamine available (Sigma Chemical).
Statistical analysis. Comparisons between two groups of data were done using Student's t-test, whereas comparisons among multiple groups were made using ANOVA with multiple comparisons by the method of Scheffé (32) and by single group t-test (GraphPad InStat). All data are presented as means Ϯ SE. 4 Cl loading on serum tCO 2 and potassium concentrations, and urinary tNH 3 excretion. Groups of mice (n ϭ 5 in each) received the following in their drinking water for 7 days: 2% sucrose in water, losartan (100 mg/l) in 2% sucrose, 0.3 M NH 4 Cl in 2% sucrose, or 0.3 M NH 4 Cl ϩ losartan (100 mg/l) in 2% sucrose (Table 1) . Mice receiving losartan and sucrose in the drinking solution displayed no significant differences in serum tCO 2 concentrations or in urinary tNH 3 excretion per milligram of creatinine compared with control mice receiving sucrose alone. However, mice receiving NH 4 Cl displayed lower serum tCO 2 concentra- 4 Cl without losartan (P Ͻ 0.01). Serum potassium concentrations did not significantly differ among the study groups. Urine pH from acid-loaded mice, as measured by pH paper, was low (pH 5.5 to 6.0) in both losartan-treated and -untreated mice. Thus, although losartan by itself had no effect on renal tNH 3 excretion, coadministration of losartan with the NH 4 Cl treatment significantly attenuated the acidosis-induced enhancement in renal tNH 3 excretion without affecting urinary pH. Losartan treatment also led to a greater reduction in the serum tCO 2 concentration in NH 4 Cl-treated mice. 4 Cl administration on tNH 3 production and net luminal tNH 3 secretion by S2 proximal tubule segments perfused in vitro. In previous studies, we demonstrated that tNH 3 production and secretion rates were enhanced in S2 proximal tubule segments derived from mice given NH 4 Cl for 7 days (24) . In the present study, we examined the effect of a 7-day exposure to NH 4 Cl with or without concurrent administration of losartan on the rates of tNH 3 production and transport by isolated S2 segments perfused in vitro under normal bicarbonate and pH concentrations. Changes in tNH 3 production and secretion that persisted after dissecting the tubule from the in vivo environment represented chronic adaptive changes. The tNH 3 production and luminal secretion rates observed in S2 segments derived from mice that received NH 4 Cl for 7 days were higher than those observed in segments from control mice not receiving NH 4 Cl. However, losartan given with the acid load blocked this increase (Fig. 1) . As depicted in Fig. 1A , the tNH 3 production rates were higher in segments from mice receiving NH 4 ; n ϭ 5 in each group, P Ͻ 0.01). As shown in Fig. 1B , the rates of net luminal tNH 3 secretion were higher in S2 segments derived from NH 4 Cl-treated mice (21.6 Ϯ 0.3 pmol ⅐ min Ϫ1 ⅐ mm Ϫ1 ) compared with segments from NH 4 Cl ϩ losartan-treated mice
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; n ϭ 5 for each group, P Ͻ 0.01). Thus, NH 4 Cl-induced metabolic acidosis was associated with adaptive increases in both tNH 3 production and luminal tNH 3 secretion rates by S2 proximal tubule segments and the administration of losartan with the NH 4 Cl blocked these adaptive increases.
Effect of 7-day acid challenge and losartan on ammoniagenic enzymes. To further explore the mechanism by which losartan prevented the adaptive enhancement of tNH 3 production, we examined the impact of losartan administration on the protein expression of two key ammoniagenic enzymes in the renal cortex: PDG and PCK1. As has been described in rats (11, 27) , PDG and PCK1 protein expression levels were enhanced with metabolic acidosis induced by 7-day NH 4 Cl acid loading [3.6 Ϯ 0.3-and 2.6 Ϯ 0.3-fold increases, respectively (n ϭ 3 for each condition, P Ͻ 0.05 vs controls)]; however, the administration of losartan had no effect on the PDG or PCK1 protein levels under acid-or nonacid-loaded conditions (Fig. 2) .
Effect of 7-day acid challenge on expression of BBMassociated NHE3. As Na ϩ -H ϩ (NH 4 ϩ ) exchange may be involved in tNH 3 secretion by the proximal tubule (14, 16), we examined the effect of acid loading on the BBM expression of an important NHE isoform, NHE3. Renal cortical BBMs from mice receiving 2% sucrose ϩ NH 4 Cl had higher levels of NHE3 expression (2.1 Ϯ 0.1-fold higher, n ϭ 3, P Ͻ 0.05) compared with those from mice receiving 2% sucrose alone. BBM NHE3 abundance was similar to levels observed in control (2% sucrose) mice than in the mice receiving 2% sucrose with losartan (relative level 1.1 Ϯ 0.1 compared with control, n ϭ 3) and in mice receiving 2% sucrose with NH 4 Cl and losartan (relative expression level 1.3 Ϯ 0.1 compared with control, n ϭ 3). These results demonstrated that BBM NHE3 expression was upregulated by acid loading as has been described by others in rats (1) and that losartan inhibited this upregulation, raising the possibility that one of the mechanisms by which losartan prevented an adaptive increase in tNH 3 Fig. 1 . Rates of total ammonia production (A) and luminal ammonia secretion (B) were significantly higher in S2 proximal tubule segments from mice given NH4Cl without losartan (ϪLOS) compared with those from control nonNH4Cl-loaded mice and NH4Cl-loaded mice given losartan (ϩLOS). *P Ͻ 0.01 compared with other groups, n ϭ 5 in each group, error bars Ϯ SE. excretion was by preventing the acid-induced increase in NHE3 BBM protein abundance.
Effect of amiloride and luminal sodium reduction on luminal tNH 3 secretion after 7-day acid challenge. We previously demonstrated that microperfusing normal mouse S2 proximal tubule segments with the low sodium perfusion solution containing 0.1 mM amiloride inhibited net luminal tNH 3 secretion by 90% (16) . These results were consistent with transport of NH 4 ϩ by a Na ϩ -H ϩ exchanger (14) . In the present study, we examined the effect of luminal perfusion with low (25 mM) sodium solution containing 0.1 mM amiloride (low Na ϩ / amiloride) on tNH 3 production and net luminal secretion rates by S2 proximal tubule segments derived from control mice and mice given NH 4 Cl. These perfusion conditions had no effect on tNH 3 Ϫ1 ⅐mm Ϫ1 vs. control perfusate 19.8 Ϯ 0.8; n ϭ 5 for each group). However, although perfusion of S2 segments with low Na ϩ /amiloride did not alter tNH 3 production, it marked reduced tNH 3 secretion under all tested conditions. As shown in Fig. 3 , rates of net luminal tNH 3 secretion were markedly lower in S2 segments from control mice perfused with the low Na ϩ /amiloride (1.3 Ϯ 0.3 pmol⅐min Ϫ1 ⅐mm
) compared with corresponding segments perfused with control KRB perfusate (9.9 Ϯ 0.9), in S2 segments from acidotic mice which were perfused in vitro with low Na ϩ /amiloride (1.9 Ϯ 0.4) compared with corresponding segments perfused with the control perfusate (19.1 Ϯ 1.0), and in segments from mice treated with NH 4 Cl and losartan which were perfused in vitro with the low Na ϩ /amiloride (0.9 Ϯ 0.5) compared with segments perfused with the control perfusate (12.1 Ϯ 1.0; P Ͻ 0.01, n ϭ 5 for each group). Thus, the enhanced tNH 3 transport mechanism observed in acidotic mice exposed to 7 days of acid loading appeared to be similar in nature to the mechanism observed in segments from control mice and in those from acid-loaded and losartan-treated mice such that in all cases, tNH 3 secretion rates were markedly inhibited by conditions that would inhibit Na ϩ -H ϩ (NH 4 ϩ ) exchange (14, 16) .
Effect of luminal ANG II on tNH 3 production and net luminal secretion rates in S2 segments derived from acidotic mice. In our previous studies, we demonstrated that addition of ANG II to the luminal perfusion solution significantly increased tNH 3 production rates in S2 segments derived from normal mice (20) . In the present study, we examined the effects of 10 Ϫ9 M ANG II into the tubule lumen on tNH 3 production and net luminal secretion rates in control mice and mice given a 7-day NH 4 Cl challenge (n ϭ 5 in each group). As depicted in Fig. 4 , addition of ANG II to the luminal perfusion solution stimulated tNH 3 production rates by S2 segments from both control mice (20.2 Ϯ 1.0 without ANG II and 32.0 Ϯ 1.6 pmol⅐min Ϫ1 ⅐mm Ϫ1 with ANG II, P Ͻ 0.01) and acidotic mice (39.8 Ϯ 1.2 pmol⅐min Ϫ1 ⅐mm Ϫ1 without ANG II vs. 50.1 Ϯ 1.1 with ANG II, P Ͻ 0.01). Thus, ANG II stimulated tNH 3 production rates by S2 proximal tubule segments from both acidotic and nonacidotic mice (P Ͻ 0.01). In previous studies, we demonstrated that the stimulatory effect of ANG II on tNH 3 production was blocked by concurrent provision of losartan in the luminal fluid (22) . The stimulatory effect of acute addition of ANG II to the luminal perfusion solution on tNH 3 production rate by S2 segments from acid-loaded mice observed here was also inhibited by the addition of losartan (10 Ϫ6 M) to the ANG II-containing luminal perfusate (40.1 Ϯ 1.5 pmol⅐min Ϫ1 ⅐mm
, Fig. 2 . Expression of proteins from 7-day nonacid-loaded or NH4Cl acidloaded mice with or without concurrent losartan. This is a representative immunoblot of experiments performed on renal tissue from 3 acidotic and 3 control mice. Phosphate-dependent glutaminase (PDG) and phosphoenolpyruvate carboxykinase 1 (PCK1) protein expression levels in renal cortical homogenates increased by 3.6 Ϯ 0.3-and 2.6 Ϯ 0.3-fold (P Ͻ 0.05 compared with control levels), respectively, and were not affected by losartan administration. By contrast, administration of losartan prevented the 2.1 Ϯ 0.1-fold increase (P Ͻ 0.05 vs. control) in brush-border membrane protein expression of the Na ϩ -H ϩ exchanger isoform 3 (NHE3) observed in response to NH4Cl treatment compared with levels observed in nonacid-loaded control mice, but had no effect on NHE3 expression in the absence of NH4Cl treatment (relative abundance ϭ 1.1 Ϯ 0.1 for nonacidotic, losartan-treated group compared with nonacidotic, nonlosartan-treated controls, P Ͼ 0.2). Fig. 3 . Luminal total ammonia secretion rates were markedly inhibited by the addition of 0.1 mM amiloride to a 25 mM sodium microperfusion solution (ϩAmil) in S2 proximal tubule segments derived from control mice, mice given NH4Cl for 7 days, and mice given NH4Cl and losartan for 7 days. All tubules were bathed in Krebs-Ringer bicarbonate (KRB) buffer with 0.5 mM L-glutamine (*P Ͻ 0.01 vs. without amiloride, n ϭ 5 for each group). As noted in RESULTS, perfusion with the 25 mM sodium ϩ amiloride perfusate had no significant effect on total ammonia production rates. P Ͻ 0.05 vs. perfusion with ANG II but without losartan). Therefore, ANG II increased tNH 3 production rates through its action on the AT1 receptor in proximal tubule segments from both acidotic and control mice.
We also tested the effect of luminal ANG II (10 Ϫ9 M) on net luminal tNH 3 secretion in S2 proximal tubule segments from control and acid-loaded mice. ANG II increased luminal tNH 3 secretion rates by S2 proximal tubule segments from control mice (ϪANG II: 11.1 Ϯ 1.0 vs. ϩANG II: 22.5 Ϯ 1.5 pmol⅐min Ϫ1 ⅐mm Ϫ1 , n ϭ 5, P Ͻ 0.01; Fig. 5 ). ANG II also stimulated net luminal tNH 3 secretion by S2 segments from mice receiving NH 4 Cl (ϪANG II: 21.6 Ϯ 0.5 vs. ϩANG II: 32.1 Ϯ 1.1 pmol⅐min Ϫ1 ⅐mm
, n ϭ 5, P Ͻ 0.01). This stimulation by ANG II of net luminal tNH 3 secretion rates in S2 segments was significantly reduced by the addition of 10
Ϫ6
M losartan with ANG II to the luminal perfusion solution in both acidotic and nonacidotic groups (12.3 Ϯ 0.8 or 20.2 Ϯ 0.9 pmol⅐ min Ϫ1 ⅐mm Ϫ1 , respectively, n ϭ 5, P Ͻ 0.01 vs. ϩANG II without losartan). Thus, ANG II acts through its type 1 (AT1) receptor to stimulate net luminal tNH 3 secretion in proximal tubule segments from acidotic and control mice.
DISCUSSION
ANG II has important effects on tNH 3 production and transport in the proximal tubule (4, 19, 20) . Acidosis in vivo is associated with upregulation of the renin-angiotensin system (6, 10, 31) . Luminal ANG II not only stimulates tNH 3 production but also stimulates tNH 3 secretion into the luminal fluid (20) . Our previous studies demonstrated that a short-term (18 h) NH 4 Cl load resulted in an adaptive increase in luminal tNH 3 secretion rates in the absence of a measurable increase in production rates in S2 proximal tubule segments (22) . The adaptive increase in tNH 3 secretion in response to NH 4 Cl loading was blocked by concurrent administration of the AT1 receptor blocker losartan.
In response to prolonged acid challenges, the kidney increases urinary tNH 3 excretion by increasing synthesis of proteins involved in tNH 3 production (7, 11, 27, 35) . In the present study, we demonstrated that prolonged (7 days) NH 4 Cl loading resulted in an increase in urinary tNH 3 excretion and in adaptive increases in both tNH 3 production and secretion rates by isolated S2 segments which were attenuated by concurrent administration of losartan with the acid load. The 7-day acid load enhanced tNH 3 production rates by S2 proximal tubule segments by 54% and secretion rates by 116% compared with nonacid-loaded controls. The enhanced secretion rates with acid loading appeared to result from a combination of the increased tNH 3 production rates as well as by an increased rate of secretion as a percentage of the total production rate, such that 69% of the tNH 3 produced by segments from acidotic mice was secreted into the lumen compared with 50% in segments from nonacidotic control mice. When losartan was given with the acid load, the tNH 3 production and secretion rates returned to levels observed in tubules from nonacidotic controls such that the proportion of secreted tNH 3 made by the proximal tubule segment was 54% compared with 50% observed in tubules from nonacidotic controls and 69% in tubules from acidotic mice. The prevention of the enhanced S2 proximal tubular tNH 3 production and secretion rates by losartan given with acid loading was associated with a reduction in urinary tNH 3 excretion and in a greater degree of NH 4 Cl-induced acidosis (lower bicarbonate concentration). The reduction in urinary tNH 3 excretion appeared to occur without a loss of the ability to acidify the urine, suggesting that distal acidification processes remained intact. In the absence of an acid load, the administration of losartan had no effect on rates of urinary tNH 3 excretion or the rates of tNH 3 production or secretion by proximal tubule segments. Thus, as is the case with briefer acid loading, the response of the proximal tubule to prolonged acid challenges depends on intact AT1 receptor function.
The mechanism by which losartan prevented acid-induced adaptive increases in urinary tNH 3 excretion and in proximal tubular rates of tNH 3 production and secretion depended, in part, on the prevention in the adaptive increase in NHE3 expression that normally occurs with acidosis (1) . In our mouse model of in vivo acidosis, we noted a losartan-inhibitable Fig. 4 . ANG II (10 Ϫ9 M) added to the lumen perfusion solution increased total ammonia production rates in S2 proximal tubule segments derived from control and acidotic mice. The increment in rate was similar in both groups. Losartan blocked the stimulatory effect of ANG II on production rates. *P Ͻ 0.01 vs. other groups, n ϭ 5 for each group.
Fig. 5. ANG II (10
Ϫ9 M) added to the lumen perfusion fluid resulted in higher luminal ammonia secretion rates by S2 segments derived from acidotic and nonacidotic controls. The increment in rates observed with ANG II was similar in both groups (*P Ͻ 0.01 vs. control no ANG group; **P Ͻ 0.01 vs. corresponding losartan-treated or ANG II-untreated S2 segment groups, n ϭ 5 for each group).
increase in BBM-associated NHE3 protein. As we described previously, and as was again demonstrated in this study, blockade of NHE (luminal perfusion with a 25 mM sodium perfusate and 0.1 mM amiloride) largely blocked tNH 3 entry into the lumen. However, the acute inhibition of NHE activity did not acutely affect tNH 3 production rates. Therefore, although a chronic reduction of NHE3 expression on the BBM by losartan could reduce luminal transport activity of tNH 3 , it is unclear whether the prevention of the acid-induced increase in NHE3 also fully explains the ability of losartan to inhibit the adaptive increase in tNH 3 production. Nevertheless, it is possible that enhancing tNH 3 transport out of the cells and into the lumen kinetically favors the forward reactions for generating tNH 3 due to rapid product removal and that reducing this efflux pathway in a sustained manner could dampen production rates.
We examined the effects of NH 4 Cl loading and losartan on expression of key ammoniagenic enzymes: PDG and PCK1 (11, 27) . In the present studies, we found that the protein expression levels of these enzymes in renal cortical tissue were increased with acid loads, but losartan had no effect on their expression levels under control or acid-loaded conditions. Therefore, since we suspect that inhibition of tNH 3 production may not be completely explained by a reduction in the transport of tNH 3 (noting the lack of an acute effect of inhibition of luminal tNH 3 secretion on total production rates), the existence of other undefined losartan-sensitive, acid-adaptive ammoniagenic pathways is likely and will be explored in future studies.
The major transport mechanism responsible for increased transport of tNH 3 with NH 4 Cl treatment appeared to be fundamentally the same as the mechanism present under nonacid loading conditions. As occurred in proximal tubules from control mice (16), luminal tNH 3 secretion rates observed in proximal tubule segments from NH 4 Cl-treated acidotic mice were substantially inhibited by perfusion of the luminal fluid with a low sodium perfusate containing amiloride. Thus, net luminal tNH 3 secretion by S2 segments from control and acid-treated mice may be mediated via a Na ϩ -H ϩ exchanger (16) acting as a Na ϩ -NH 4 ϩ exchanger. As mentioned previously, acid loading increased brush-border expression of NHE3 and this increase was prevented by providing losartan with the acid load. Therefore, the enhanced transport rate observed in S2 segments from acidotic mice may be due to the induction of additional tNH 3 transporters.
As in S2 segments from nonacidotic mice (20) and mice receiving an 18-h NH 4 Cl challenge, luminal ANG II markedly stimulated tNH 3 production and secretion rates in proximal tubule segments from mice receiving NH 4 Cl for 7 days. One difference between the results observed in the present study compared with our previous observations was that the ANG II-induced increment in rates of tNH 3 production and secretion rates after the 7-day acid load appeared to be quantitatively similar in tubules derived from acidotic and nonacidotic mice, whereas a briefer acid challenge was associated with an enhanced stimulatory response to ANG II. In either case, however, luminal ANG II stimulated tNH 3 production and secretion rates beyond the levels observed with acid challenge alone. When measured in vivo, ANG II has been found in the fluid of the tubule lumen at the concentrations used in the present experiments (25, 34) . Therefore, our experimental addition of ANG II to the luminal perfusion solution may actually reflect the "native" state in the nephron in vivo and, with 18-h or 7-day acid challenges, ANG II would probably be present in sufficient quantities to enhance the renal response to either short-term or long-term acid challenges.
In human subjects, ANG II may be important in maintaining high renal tNH 3 excretion rates in individuals with experimentally induced acidosis (10) . Although Henger and co-workers (10) demonstrated that individuals given an acid load may display a reduction in urinary ammonia and net acid excretion in response to angiotensin receptor blockade, treatment with anti-angiotensin agents which are commonly used in patients with chronic kidney disease and hypertension are infrequent causes of metabolic acidosis. However, upon exposure to high acid loads, humans may develop overt acid-base problems with type 1 angiotensin receptor blockade similar to the mice used in this study.
In summary, we showed that 1) 7 days of NH 4 Cl loading results in acidosis in vivo, enhanced urinary tNH 3 excretion, and enhanced tNH 3 production and net luminal secretion rates by isolated perfused mouse S2 segments derived from acidotic mice; 2) ANG II acting through its type 1 receptor is necessary for this adaptive increase in urinary tNH 3 excretion and S2 proximal tubule tNH 3 production and secretion rates; 3) ANG II added to the tubule lumen stimulated tNH 3 production and secretion in S2 segments from acidotic and nonacidotic control mice; and 4) acid loading also enhances protein expression levels of PDG, PCK1, and NHE3, but only upregulation of brush-border NHE3 expression is blocked by provision of losartan with the acid load. Taken together, these results indicate that ANG II plays a critical role in the adaptation and response of the proximal tubule to prolonged acid challenges.
